Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Crush implantation of a self-expanding interwoven stent over a subintimally recanalized standard stent in a TASC D lesion of the superficial femoral artery.

Vogel B, Strothmeyer A, Cebola R, Katus H, Blessing E.

Vasa. 2012 Nov;41(6):458-62. doi: 10.1024/0301-1526/a000238.

PMID:
23129042
[PubMed - indexed for MEDLINE]
2.

Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia.

Lichtenberg M, Stahlhoff W, Boese D.

J Cardiovasc Surg (Torino). 2013 Aug;54(4):433-9.

PMID:
24013531
[PubMed - indexed for MEDLINE]
3.

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.

McQuade K, Gable D, Pearl G, Theune B, Black S.

J Vasc Surg. 2010 Sep;52(3):584-90; discussion 590-1, 591.e1-591.e7. doi: 10.1016/j.jvs.2010.03.071.

PMID:
20598480
[PubMed - indexed for MEDLINE]
Free Article
4.

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.

McQuade K, Gable D, Hohman S, Pearl G, Theune B.

J Vasc Surg. 2009 Jan;49(1):109-15, 116.e1-9; discussion 116. doi: 10.1016/j.jvs.2008.08.041. Epub 2008 Nov 22.

PMID:
19028055
[PubMed - indexed for MEDLINE]
Free Article
5.

Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.

Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Cao AY, Jaff MR; RESILIENT Investigators.

J Endovasc Ther. 2012 Feb;19(1):1-9. doi: 10.1583/11-3627.1.

PMID:
22313193
[PubMed - indexed for MEDLINE]
6.

Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.

Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M.

J Vasc Surg. 2010 Sep;52(3):608-15. doi: 10.1016/j.jvs.2010.03.050. Epub 2010 Jun 22.

PMID:
20573476
[PubMed - indexed for MEDLINE]
Free Article
7.

Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.

Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, Peeters P.

J Vasc Surg. 2011 Oct;54(4):1042-50. doi: 10.1016/j.jvs.2011.03.272. Epub 2011 Jun 2.

PMID:
21636239
[PubMed - indexed for MEDLINE]
Free Article
8.

Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery.

Sakamoto Y, Hirano K, Iida O, Soga Y, Suzuki K, Muramatsu T, Tsukahara R.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E251-6. doi: 10.1002/ccd.24935. Epub 2013 Apr 25.

PMID:
23536429
[PubMed - indexed for MEDLINE]
9.

Primary stenting of the superficial femoral and popliteal artery.

Dearing DD, Patel KR, Compoginis JM, Kamel MA, Weaver FA, Katz SG.

J Vasc Surg. 2009 Sep;50(3):542-7. doi: 10.1016/j.jvs.2009.04.019. Epub 2009 Jun 21.

PMID:
19540706
[PubMed - indexed for MEDLINE]
Free Article
10.

Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.

Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills JL Sr, Goshima KR, Echeverri JA, Arslan B.

J Vasc Surg. 2008 May;47(5):967-74. doi: 10.1016/j.jvs.2007.12.050. Epub 2008 Apr 18.

PMID:
18372147
[PubMed - indexed for MEDLINE]
Free Article
11.

Incidence and clinical implications of stent fractures of the Xpert self-expanding nitinol stent in infrainguinal arteries.

Keo HH, Kickuth R, Diehm N, Baumgartner I, Dai-Do D.

Vasa. 2009 Feb;38(1):47-52. doi: 10.1024/0301-1526.38.1.47.

PMID:
19229803
[PubMed - indexed for MEDLINE]
12.

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).

Matsumura JS, Yamanouchi D, Goldstein JA, Pollock CW, Bosiers M, Schultz GA, Scheinert D, Rocha-Singh KJ.

J Vasc Surg. 2013 Jul;58(1):73-83.e1. doi: 10.1016/j.jvs.2012.12.066. Epub 2013 May 2.

PMID:
23642924
[PubMed - indexed for MEDLINE]
Free Article
13.

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.

Kawamura Y, Ishii H, Aoyama T, Tanaka M, Takahashi H, Kumada Y, Toriyama T, Murohara T.

J Vasc Surg. 2009 Nov;50(5):1057-62. doi: 10.1016/j.jvs.2009.07.017. Epub 2009 Sep 26.

PMID:
19782527
[PubMed - indexed for MEDLINE]
Free Article
14.

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.

Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators.

Circ Cardiovasc Interv. 2010 Jun 1;3(3):267-76. doi: 10.1161/CIRCINTERVENTIONS.109.903468. Epub 2010 May 18.

PMID:
20484101
[PubMed - indexed for MEDLINE]
Free Article
15.

Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years.

Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Nagata S.

JACC Cardiovasc Interv. 2009 Jul;2(7):665-71. doi: 10.1016/j.jcin.2009.04.014.

PMID:
19628191
[PubMed - indexed for MEDLINE]
Free Article
16.

Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.

Davaine JM, Quérat J, Guyomarch B, Brennan MÁ, Costargent A, Chaillou P, Patra P, Gouëffic Y.

Eur J Vasc Endovasc Surg. 2013 Aug;46(2):201-12. doi: 10.1016/j.ejvs.2013.05.010. Epub 2013 Jun 15.

PMID:
23773773
[PubMed - indexed for MEDLINE]
Free Article
17.

Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.

Goltz JP, Ritter CO, Kellersmann R, Klein D, Hahn D, Kickuth R.

J Endovasc Ther. 2012 Jun;19(3):450-6. doi: 10.1583/11-3591MR.1.

PMID:
22788900
[PubMed - indexed for MEDLINE]
18.

Primary nitinol stenting for femoropopliteal disease.

Mewissen MW.

J Endovasc Ther. 2009 Apr;16(2 Suppl 2):II63-81. doi: 10.1583/08-2658.1. Review.

PMID:
19624075
[PubMed - indexed for MEDLINE]
19.

Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.

Ascher E, Marks NA, Hingorani AP, Schutzer RW, Mutyala M.

J Vasc Surg. 2006 Dec;44(6):1230-7; discussion 1237-8. Epub 2006 Oct 20.

PMID:
17055689
[PubMed - indexed for MEDLINE]
Free Article
20.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.

Chan YC, Cheng SW, Ting AC, Cheung GC.

J Vasc Surg. 2014 Feb;59(2):384-91. doi: 10.1016/j.jvs.2013.08.037.

PMID:
24461862
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk